Literature DB >> 6201584

Mechanisms of Ly2 suppressor cell activity. Activation of an Ly1 I-J+ cell is required to transduce the suppressive signal.

P M Flood, D C Louie.   

Abstract

A cell-free product secreted by Ly1-2+ T cells (Ly2 TsF) can suppress the in vitro response to sheep erythrocytes (SRBC) of spleen cells depleted of Ly2+ T cells. This suppressor factor expresses biological activity only when the acceptor cells share major histocompatibility complex (MHC)-linked polymorphic genes with the cells that made the Ly2 TsF. Removal of Ly1 I-J+ cells from the assay culture abrogates the ability of Ly2 TsF to suppress these cultures, but we can replace the need for the I-J+ cells in the assay culture with an I-J+ soluble factor derived from them. We investigated the cellular interactions involved in the activation of I-J+ cells by Ly2 TsF in vitro. We have been able to induce the production of an I-J+ molecule needed for Ly2 TsF activity in a 48-h intermediate culture of B cell-depleted Ly1 spleen cells, Ly2 TsF, and antigen. This molecule not only fails to bind antigen, but is also antigen nonspecific in that it can be induced by Ly2 TsF of irrelevant specificities. In order to replace the activity of the Ly1 I-J+ cell in the assay culture, the cell induced by Ly2 TsF to produce the I-J+ molecule in vitro must share genetic polymorphisms linked to the MHC with the Ly2 TsF, and genetic polymorphisms linked to the Igh-V gene complex with the target cell. In order for Ly2 TsF to induce cells of the primary culture to produce the I-J+ molecule, Ly2 TsF must share genetic polymorphisms linked to the IE region of the MHC with the Ly1 I-J+ cell producing the I-J+ molecule. These results indicate that the suppressive mechanism of Ly2 TsF involves the interaction with an Ly1 I-J+ molecule. This I-J+ molecule serves to focus the antigen-specific suppressor molecule on the target cell. The recognition event of this suppressive complex on the surface of the acceptor cell is controlled by Igh-V-linked genes restricted by the I-J+ molecule of the suppressor complex. This suppressor interaction is confined to the suppressor effector phase of the suppressor circuit since the I-J+ molecules needed for by Ly2 TsF activity do not substitute for the I-J+ molecules needed for the activity of Ly1 TsiF , a T cell factor that initiates the suppressor cell circuit.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201584      PMCID: PMC2187305          DOI: 10.1084/jem.159.5.1413

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  18 in total

1.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

2.  A non-T:non-B cell bears I-A, I-E, I-J, and Tla (Qa-1?) determinants.

Authors:  S Habu; K Yamauchi; R K Gershon; D B Murphy
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Structure of an antigen-specific suppressor factor produced by a hybrid T-cell line.

Authors:  M J Taussig; A Holliman
Journal:  Nature       Date:  1979-01-25       Impact factor: 49.962

4.  Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors.

Authors:  M S Sy; M H Dietz; R N Germain; B Benacerraf; M I Greene
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

5.  Antigen presentation in the murine T-lymphocyte proliferative response. I. Requirement for genetic identity at the major histocompatibility complex.

Authors:  A Yano; R H Schwartz; W E Paul
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

6.  Regulatory mechanisms in cell-mediated immune responses. III. I-region control of suppressor cell interaction with responder cells in mixed lymphocyte reactions.

Authors:  S S Rich; R R Rich
Journal:  J Exp Med       Date:  1976-03-01       Impact factor: 14.307

7.  Presence of interchain disulfide bonds between two gene products that compose the secreted form of an antigen-specific suppressor factor.

Authors:  M Taniguchi; T Saito; I Takei; T Tokuhisa
Journal:  J Exp Med       Date:  1981-06-01       Impact factor: 14.307

8.  Properties of the antigen-specific suppressive T-cell factor in the regulation of antibody response of the mouse. IV. Special subregion assignment of the gene(s) that codes for the suppressive T-cell factor in the H-2 histocompatibility complex.

Authors:  T Tada; M Taniguchi; C S David
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

9.  Antigen-specific T lymphocyte clones. II. Purification and biological characterization of an antigen-specific suppressive protein synthesized by cloned T cells.

Authors:  M Fresno; L McVay-Boudreau; G Nabel; H Cantor
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  Antigen-specific T lymphocyte clones. I. Characterization of a T lymphocyte clone expressing antigen-specific suppressive activity.

Authors:  M Fresno; G Nabel; L McVay-Boudreau; H Furthmayer; H Cantor
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Induction of contrasuppression is restricted by genes mapping to the IgH locus.

Authors:  D R Green; B Chue; P M Flood
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

2.  Augmentation of delayed-type hypersensitivity to high dose sheep erythrocytes by cyclosporin A in the mouse: influence of drug dosage and route of administration and analysis of spleen cell populations.

Authors:  L M Webster; A W Thomson
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

3.  Temporal changes of suppressor T lymphocytes and cytotoxic T lymphocytes in syngeneic murine malignant gliomas.

Authors:  T Yamasaki; H Handa; J Yamashita; Y Namba; M Hanaoka
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.